Abbott 2004 Global Citizenship Report - Abbott Laboratories

About AbbottThe story of Abbott’s Promise began in 1888 with a young physiciannamed Wallace Calvin Abbott.60%50%40%30%20%10%0%-10%-20%-30%-40%-50%-60%The story of Abbott’s Promise began in 1888 with a youngphysician named Wallace Calvin Abbott. Dr. Abbott wasdissatisfied with contemporary processes for makingpharmaceuticals. Most medicines at the time were madeusing a fluid extraction method: plants and herbs weresoaked in alcohols and the medicinal properties extractedfrom the leaves. The effects were imprecise andunpredictable. Dr. Abbott thought there was a better way.He began to produce granules based on the alkaloids ofmedicinal plants – the parts that actually produced medicaleffect – and the Abbott Alkaloidal Company was born.Dr. Abbott was a part of a pioneering generation ofdoctors, pharmacists and scientists who helped createmodern medicine. Their work, and that of the generationswho have followed, has resulted in the most significantimprovements in human health in our history. We have theability today to prevent, diagnose, treat and cure morediseases than were even known to exist in their time.Dr. Abbott’s vision continues to guide our company.Today, Abbott is a broad-based health care company thatdiscovers, develops, manufactures and markets productsthat span the continuum of care. Our products, whichrange from pharmaceuticals and diagnostic assays tonutritionals and medical devices, address some of theworld’s most important medical needs.Abbott serves customers in more than 130 countries,with more than 60,000 employees in 72 countries atAbbott and Peer GroupFive-Year Total Return(through December 31, 2004)52.5NVS52.2ABT46.8JNJ19.86.8-4.5WYE AMGN GSK-6.6LLY-10.7PFE-42.4-45.7-50.6MRKSGPBMY3.5DOW14.6S&PHLTH-11.0S&P500more than 100 manufacturing, distribution, research anddevelopment, and other facilities. More than half of Abbottemployees are located outside of the United States.In 2004, Abbott achieved record sales of $19.7 billion andincome from continuing operations of $3.7 billion. Ouroperating cash flow from continuing operations exceeded$4.3 billion. In December 2004, Abbott also declared the324th consecutive quarterly dividend to be paid toshareholders since 1924.Our stock outperformed both the S&P 500 and the S&PHealth Index in 2004. Our total return, including stockappreciation and dividend payouts in 2004, was 9.7 percent.Complete financial information on Abbott and a list of ourproducts are available at www.abbottinvestor.com.All Other Countries4,595Italy745The Netherlands705Canada595Germany811Japan987International6,166U.S.Nutritionals2,3262004 Net Sales(dollars in millions)Total: 19,6802004 Net Sales by Segment(dollars in millions)Other800United States11,242Total: 19,680WorldwideDiagnostics3,378U.S.Pharmaceuticals7,0104